Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe, page-65

Let me elaborate on my previous post

Example

Pyc has a MC $203.6 million
Anp has a miserable MC $ 53.5 million

ok: so that’s established

Pyc is still in Animal studies ( market $1 billion)
Anp is also in animal studies.
However
Limb Girdle . And other indications will have accelerated approval because off the safety data already generated.(market $4 billion just on LG)


Now
Anp moving forward with DMD is a given : Replicate the end points from the last trial and we have commercialisation .$$
Anp is confident besides LG we will have many other muscular degenerative indications to follow
But wait:
MS is a neuromuscular disease..
and my DD tells me there are many indications to follow
Eg..Dementia ( inflammation of the brain)

conclusion:
Akki: your Hyundai is a standard 130i
Anp is the top of the range Santa Fe with all the bells and whistles..

So compare both Market Caps and see there is a huge space between both
Anp to achieve a Mc of $203.6 mill is a no brainer.